V

Vistin Pharma ASA
OSE:VISTN

Watchlist Manager
Vistin Pharma ASA
OSE:VISTN
Watchlist
Price: 23.6 NOK -0.42% Market Closed
Market Cap: 1B NOK

Intrinsic Value

The intrinsic value of one VISTN stock under the Base Case scenario is 20.8 NOK. Compared to the current market price of 23.6 NOK, Vistin Pharma ASA is Overvalued by 12%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VISTN Intrinsic Value
20.8 NOK
Overvaluation 12%
Intrinsic Value
Price
V
Worst Case
Base Case
Best Case

Valuation History
Vistin Pharma ASA

VISTN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for VISTN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Vistin Pharma ASA
OSE:VISTN
NO
Pharmaceuticals
Market Cap
1B NOK
IPO
Jun 10, 2015
NO
Pharmaceuticals
Market Cap
1B NOK
IPO
Jun 10, 2015
Price
krfalse
EPS
krfalse
Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about VISTN?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Vistin Pharma ASA
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vistin Pharma ASA

Current Assets 143.2m
Cash & Short-Term Investments 12.8m
Receivables 53.7m
Other Current Assets 76.7m
Non-Current Assets 241.8m
Long-Term Investments 12.2m
PP&E 229.6m
Other Non-Current Assets 1k
Efficiency

Free Cash Flow Analysis
Vistin Pharma ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Vistin Pharma ASA

Revenue
429.5m NOK
Cost of Revenue
-150m NOK
Gross Profit
279.5m NOK
Operating Expenses
-194.2m NOK
Operating Income
85.3m NOK
Other Expenses
-22.5m NOK
Net Income
62.8m NOK
Fundamental Scores

VISTN Profitability Score
Profitability Due Diligence

Vistin Pharma ASA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
ROE is Increasing
ROIC is Increasing
Positive 3-Years Revenue Growth
56/100
Profitability
Score

Vistin Pharma ASA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

VISTN Solvency Score
Solvency Due Diligence

Vistin Pharma ASA's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
76/100
Solvency
Score

Vistin Pharma ASA's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VISTN Price Targets Summary
Vistin Pharma ASA

There are no price targets for VISTN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for VISTN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest
What is the Intrinsic Value of one VISTN stock?

The intrinsic value of one VISTN stock under the Base Case scenario is 20.8 NOK.

Is VISTN stock undervalued or overvalued?

Compared to the current market price of 23.6 NOK, Vistin Pharma ASA is Overvalued by 12%.

Back to Top